All Work

Chris Lange

What Else Is Under the Hood for Catalyst Pharma?

ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton Myasthenic Syndrome, or LEMS. In the study, Firdapse was reported…

Chris Lange · 12 years ago

MLP PennTex Files for IPO

PennTex Midstream Partners has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Chris Lange · 12 years ago

Consumer Confidence Hits the Skids

The Conference Board released the reading on consumer confidence for the month of September, and the it looks like confidence hit the skids.

Chris Lange · 12 years ago

Boot Barn Files for IPO

Boot Barn Holdings Inc. filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering

Chris Lange · 12 years ago

Analyst Shows Why Nike Is Worth $100

Wikimedia CommonsCredit Suisse issued a research report today that Nike, Inc. (NYSE: NKE) might be worth more than previously thought. In the wake of a strong earnings report, Nike seems poised more than ever to finish…

Chris Lange · 12 years ago

Full Walgreen Earnings Preview

Courtesy of WalgreenWalgreen Co. (NYSE: WAG) is set to report its earnings before the market opens Tuesday. This drugstore retail giant hopes to turn around investors’ negativity after a rough month of August that…

Chris Lange · 12 years ago

Is BlackBerry Stock Now Fairly Priced?

Many investors remain confused about BlackBerry's turnaround hopes. It appears that analysts are struggling to find equilibrium as well.

Chris Lange · 12 years ago

Is TIBCO’s Buyout Fairly Valued?

TIBCO Software announced Monday morning that private equity firm Vista Equity Partners would be taking it private.

Chris Lange · 12 years ago